Goodnick P J, Fieve R R, Schlegel A, Kaufman K
Acta Psychiatr Scand. 1987 Jun;75(6):601-3. doi: 10.1111/j.1600-0447.1987.tb02842.x.
Forty-two patients with a history of affective disorder on lithium prophylaxis alone participated in a prospective 1-year study of inter-episode symptoms. Despite expected significant differences in mean plasma lithium level in patients, those with mean levels above the median (0.82 +/- 0.10 mEq/l) did not differ in incidence of major symptoms per visit, in mood shift per visit, or in rate of subclinical symptoms on the General Behavior Inventory from those patients with mean level below the median (0.52 +/- 0.09 mEq/l).
42名仅接受锂盐预防治疗的情感障碍患者参与了一项为期1年的发作间期症状前瞻性研究。尽管患者的平均血浆锂水平存在预期的显著差异,但平均水平高于中位数(0.82±0.10 mEq/l)的患者与平均水平低于中位数(0.52±0.09 mEq/l)的患者相比,每次就诊时主要症状的发生率、每次就诊时的情绪变化或一般行为量表上的亚临床症状发生率并无差异。